Literature DB >> 8883429

Margaret Holroyd Prize Essay. A patient-centred approach to evaluation and treatment in rheumatoid arthritis: the development of a clinical tool to measure patient-perceived handicap.

A J Carr1.   

Abstract

Assessment of patient-centered outcomes is of particular importance in a chronic disease such as rheumatoid arthritis (RA), where a major aim of treatment is a reduction of its disabling and handicapping effects. Rheumatology is reasonably well advanced in its deployment of such outcomes. Measurement of the patient's experience of disease has focused on the ability to perform daily living tasks and, latterly, on the more global effect on quality of life. Neither of these approaches is without conceptual and measurement problems. A new measure of patient-centred outcome in RA has been developed (Carr AJ, Br J Rheumatol 1994;33:378-82). This tool, the Disease Repercussion Profile (DRP), attempts to extend the measurement of outcome to incorporate the individual functional, social, psychological, emotional and economic disadvantage resulting from RA, i.e. patient-perceived handicap. It has been designed for use as a clinical tool, to allow patients to specify the problems and needs of most importance to them, and as such represents a new approach. This paper reviews the development of the DRP in the context of existing health status measures and examines its potential role as a routine measure in an out-patient setting.

Entities:  

Mesh:

Year:  1996        PMID: 8883429     DOI: 10.1093/rheumatology/35.10.921

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  14 in total

Review 1.  Are quality of life measures patient centred?

Authors:  A J Carr; I J Higginson
Journal:  BMJ       Date:  2001-06-02

2.  Measuring quality of life: Using quality of life measures in the clinical setting.

Authors:  I J Higginson; A J Carr
Journal:  BMJ       Date:  2001-05-26

3.  Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis.

Authors:  P P Katz; A Morris; E H Yelin
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

4.  Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis?

Authors:  M C Greenwood; D V Doyle; M Ensor
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  A randomised controlled trial. Shifting boundaries of doctors and physiotherapists in orthopaedic outpatient departments.

Authors:  G Daker-White; A J Carr; I Harvey; G Woolhead; G Bannister; I Nelson; M Kammerling
Journal:  J Epidemiol Community Health       Date:  1999-10       Impact factor: 3.710

6.  Values for function in rheumatoid arthritis: patients, professionals, and public.

Authors:  S Hewlett; A P Smith; J R Kirwan
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

7.  Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ).

Authors:  S Hewlett; A P Smith; J R Kirwan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

8.  A randomised controlled trial of occupational therapy for people with early rheumatoid arthritis.

Authors:  A Hammond; A Young; R Kidao
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

9.  Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36.

Authors:  Elisabet West; Solveig Wållberg Jonsson
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

10.  Measuring the ICF components of impairment, activity limitation and participation restriction: an item analysis using classical test theory and item response theory.

Authors:  Beth Pollard; Diane Dixon; Paul Dieppe; Marie Johnston
Journal:  Health Qual Life Outcomes       Date:  2009-05-07       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.